Brito Ana Mafalda, Simões Ana Margarida, Alcobia Armando, Alves da Costa Filipa
Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM), Campus Universitário. Quinta da Granja. Monte da Caparica, 2829-551, Caparica, Portugal.
Hospital Garcia de Orta (HGO), EPE Av. Torrado da Silva, 2801-951, Almada, Portugal.
Int J Clin Pharm. 2017 Oct;39(5):980-984. doi: 10.1007/s11096-017-0512-9.
Introduction The domiciliary hospitalization unit (DHU) is an innovative model of care provision, where hospital care is transferred to the patients' home. However, this shift adds a care transition layer to the process, which may increase the probability of medication errors to occur. Method A pharmacist has been integrated into the DHU team to improve medication use. We developed an observational study documenting his intervention for 6 months. Information about the patient's drug therapy before admission, during hospitalization and after hospital discharge were gathered, enabling comparison of possible discrepancies that may happen during care transitions. The pharmacist evaluated the appropriateness, necessity, effectiveness, and safety of medication and intervened when deemed appropriate. Conclusions Data suggests that a pharmacist involved in the DHU may have a positive impact on medication use. Medication review and reconciliation are examples of pharmaceutical interventions that may lead to increased effectiveness and patient safety.
引言 居家住院单元(DHU)是一种创新的护理模式,即将医院护理转移到患者家中。然而,这种转变在流程中增加了护理过渡环节,这可能会增加用药错误发生的概率。方法 一名药剂师已融入DHU团队以改善用药情况。我们开展了一项观察性研究,记录他为期6个月的干预情况。收集了患者入院前、住院期间和出院后的药物治疗信息,以便比较护理过渡期间可能出现的差异。药剂师评估了用药的合理性、必要性、有效性和安全性,并在认为适当时进行干预。结论 数据表明,参与DHU的药剂师可能会对用药产生积极影响。药物审查与核对是可能提高有效性和患者安全性的药学干预措施的实例。